CVX Earnings

CVX reported its earnings on 2026-01-30, showcasing a revenue of 46.87B against an estimate of 52.66B, resulting in a -10.99% surprise. The EPS was 1.52, surpassing the expected 1.44 by 5.56% . The stock experienced a 3.34% price change on the earnings day and a 5.86% change over the next five days, reflecting market reactions to the results.

Following CVX's earnings announcement on 2026-01-30, the stock price moved by 3.34% on the day of the release. Over the subsequent five days, it saw a 5.86% change. Historically, CVX's stock price tends to shift by an average of +0.50% in the 10 days leading up to earnings and +1.75% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CVX’s annual revenue to reach 47.85B, while the EPS is projected at 1.80. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.39% and EPS estimates Revise Downward by -4.58% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CVX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.39%, while EPS estimates moved Revise Downward by -4.58% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CVX's stock price typically moves by +0.50% in the 10 days before its earnings and +1.75% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.80 and revenue of 47.85B.

The earnings call summary indicates strong financial performance with increased production and cash generation. Product development and business updates are promising, with significant progress in the Eastern Mediterranean and cost reduction efforts exceeding expectations. The market strategy is solid, focusing on cash flow growth and disciplined capital allocation. Shareholder returns are likely supported by strong financial health. Despite some concerns in the Q&A section, such as the unclear impact of Kazakhstan's compensation cuts, the overall sentiment remains positive, suggesting a potential stock price increase of 2% to 8%.